For past Congresses, use the Browse menu.
HRES 242
116th Congress • 2019–2021 (Ended)

Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.


Organizations below reported lobbying activity that included this bill as a disclosed issue. Expand to view filing details.
Loading filings…